Stay updated on XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.6.3 is added and the previous v3.6.2 revision is removed in the study record history, indicating a metadata update to the page’s history rather than substantive changes to the study data.SummaryDifference0.1%

- Check9 days agoChange DetectedA new release entry, Revision: v3.6.2, was added to the Record History; the older entry Revision: v3.6.0 was removed from the visible history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe study history now shows that recruitment has closed (no longer looking for participants). The history also records a new revision tag (v3.6.0) and removes the previous revision (v3.5.5).SummaryDifference0.4%

- Check31 days agoChange DetectedA new revision entry labeled v3.5.5 was added to the history. The previous revision v3.5.4 was removed, updating the version history of the record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe history page now shows Revision: v3.5.4, signaling a newer release of the interface. This update reflects a system or UI upgrade rather than adjustments to the underlying study records.SummaryDifference0.1%

- Check60 days agoChange DetectedA new version entry dated 2026-05-05 appears with a Study Status change (version 12), and the previous entry dated 2025-07-17 is deleted from the history.SummaryDifference0.4%

Stay in the know with updates to XmAb®20717 in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Metastatic Prostate Cancer Clinical Trial page.